Firasat et al., 2008 - Google Patents
Primary congenital glaucoma localizes to chromosome 14q24. 2-24.3 in two consanguineous Pakistani familiesFirasat et al., 2008
View HTML- Document ID
- 11961815075138205881
- Author
- Firasat S
- Riazuddin S
- Hejtmancik J
- Riazuddin S
- Publication year
- Publication venue
- Molecular vision
External Links
Snippet
Purpose Two consanguineous Pakistani families with autosomal recessive primary congenital glaucoma were recruited to identify the disease locus. Methods Ophthalmic examinations including slit lamp biomicroscopy and applanation tonometry were employed …
- 201000006672 primary congenital glaucoma 0 title abstract description 46
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Hybridisation probes
- C12Q1/6883—Hybridisation probes for diseases caused by alterations of genetic material
- C12Q1/6886—Hybridisation probes for diseases caused by alterations of genetic material for cancer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/172—Haplotypes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/118—Prognosis of disease development
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/112—Disease subtyping, staging or classification
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Gargiulo et al. | Molecular and clinical characterization of albinism in a large cohort of Italian patients | |
Bisceglia et al. | VSX1 mutational analysis in a series of Italian patients affected by keratoconus: detection of a novel mutation | |
Hansen et al. | Genetic heterogeneity in microcornea-cataract: five novel mutations in CRYAA, CRYGD, and GJA8 | |
Abu-Amero et al. | Screening of CYP1B1 and LTBP2 genes in Saudi families with primary congenital glaucoma: genotype-phenotype correlation | |
Challa et al. | Analysis of LOXL1 polymorphisms in a United States population with pseudoexfoliation glaucoma | |
Firasat et al. | Primary congenital glaucoma localizes to chromosome 14q24. 2-24.3 in two consanguineous Pakistani families | |
Payne et al. | Dominant optic atrophy, sensorineural hearing loss, ptosis, and ophthalmoplegia: a syndrome caused by a missense mutation in OPA1 | |
Panicker et al. | Identification of novel mutations causing familial primary congenital glaucoma in Indian pedigrees | |
Aldave et al. | No VSX1 gene mutations associated with keratoconus | |
Ozaki et al. | Association of LOXL1 gene polymorphisms with pseudoexfoliation in the Japanese | |
López-Garrido et al. | Heterozygous CYP1B1 gene mutations in Spanish patients with primary open-angle glaucoma | |
Sullivan et al. | Genomic rearrangements of the PRPF31 gene account for 2.5% of autosomal dominant retinitis pigmentosa | |
Mossböck et al. | Lysyl oxidase-like protein 1 (LOXL1) gene polymorphisms and exfoliation glaucoma in a Central European population | |
Hameed et al. | A novel locus for Leber congenital amaurosis (LCA4) with anterior keratoconus mapping to chromosome 17p13 | |
Gwilliam et al. | Posterior polymorphous corneal dystrophy in Czech families maps to chromosome 20 and excludes the VSX1 gene | |
Bhattacharjee et al. | Leu432Val polymorphism in CYP1B1 as a susceptible factor towards predisposition to primary open-angle glaucoma | |
Yang et al. | Genetic association of LOXL1 gene variants and exfoliation glaucoma in a Utah cohort | |
Bandah-Rozenfeld et al. | Novel null mutations in the EYS gene are a frequent cause of autosomal recessive retinitis pigmentosa in the Israeli population | |
Puomila et al. | Dominant optic atrophy: correlation between clinical and molecular genetic studies | |
Sheikh et al. | Mutational spectrum of the CYP1B1 gene in Pakistani patients with primary congenital glaucoma: novel variants and genotype-phenotype correlations | |
Mookherjee et al. | WDR36 variants in East Indian primary open-angle glaucoma patients | |
Mabuchi et al. | Lysyl oxidase-like 1 gene polymorphisms in Japanese patients with primary open angle glaucoma and exfoliation syndrome | |
Xu et al. | Novel PRPF31 mutations associated with Chinese autosomal dominant retinitis pigmentosa patients | |
Avila-Fernandez et al. | CERKL mutations and associated phenotypes in seven Spanish families with autosomal recessive retinitis pigmentosa | |
López-Martínez et al. | Role of MYOC and OPTN sequence variations in Spanish patients with primary open-angle glaucoma |